Why 2026 Could Be a Breakout Year for Private Biotech FundingFeb 43 min readAfter a difficult 3 years of private biotech funding for early-stage biotech companies (FN1, FN2), we predict that 2026 will be a breakout year. Why? Want to read more?Subscribe to bpiq.com to keep reading this exclusive post. Subscribe Now